Abstract:The hallmarks of cancer was proposed to elucidate the common trajectory of tumors of different tissues of origin and genetic makeups, which were expected to attributed to disruption of regulatory pathways conferring survival and growth advantages to tumor tissues. However, the specific biological processes involved in each milestones in the trajectory of development of lung adenocarcinoma, particularly regarding tumor stages, remain elusive. The datasets of The Cancer Genome Atlas (TCGA) project lend potential for discovering the distinctive expressional patterns of differentiated subpopulations, and exploring the dynamic evolution of biological activities within tumor cells. RNA sequencing level 3 data of 56 pairs of tissue and adjacent normal samples were obtained from TCGA. Differential expression analysis was conducted using ‘edgeR’ package across the each tumor stage. Differentially expressed genes were derived with fold change>=4 and FDR <= 0.01, followed by KEGG pathway analysis. Odd ratios (ORs) were extracted to indicate the degrees of dysregulation of each pathway. After removing non-cancer associated pathways from the 77 pathways identified as dysregulated in those samples, we arrived at 35 pathways. In “Cell cycle” and “Pathways in cancer”, ORs display positive correlation with tumor stages, and the Stage IV showed appreciably higher OR than other stages. Noteworthily, Stage IV has very high Ors in “PPAR signaling pathway”, “Renin-angiotensin system” and “p53 signaling pathway”, which represents canonical pathways implicated in cancer pathologies. We identified pathways that display correlation with tumor stages, although some deviations are expected to stem from differences in treatment, complicated disease, and health conditions, etc. These results display considerable linear correlation between the degree of dysregulation of cancer pathways, which promise applying RNA sequencing in characterizing the bona fide cell fate of tumor tissues.

Average fold-change of genetic pathways in biological transitions

Figure S1 from Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors

Identification of Regulatory Variables for State Transition of Biological Networks.

Gene expression rearrangements denoting changes in the biological state

Geometric analysis of pathways dynamics: application to versatility of TGF-β receptors

P1.03-05 Transcriptome Landscape of Lung Adenocarcinoma Patients Revealed Distinct Trajectory Patterns

Integrating gene regulatory pathways into differential network analysis of gene expression data

Data-driven energy landscape reveals critical genes in cancer progression

Gene Regulatory Network Based Biomarker Transition from Normalcy to Malignancy: A study of Lung Cancer Using Differential Gene Expression Data

Identification of changes in gene expression

On the gene expression landscape of cancer

Estimation of Non-Equilibrium Transition Rate from Gene Expression Data

Quantifying the Underlying Landscape and Paths of Cancer

Pattern‐centric transformation of omics data grounded on discriminative gene associations aids predictive tasks in TCGA while ensuring interpretability

Estimating the number of available states for normal and tumor tissues in gene expression space

Cancer prediction with gene expression profiling and differential evolution

Tissue-adjusted pathway analysis of cancer (TPAC): A novel approach for quantifying tumor-specific gene set dysregulation relative to normal tissue

Integrated Analysis of the Gene Expression Changes During Colorectal Cancer Progression by Bioinformatic Methods

Identification of Monotonically Differentially Expressed Genes across Pathologic Stages for Cancers

A multi-platform normalization method for meta-analysis of gene expression data

Gene Expression Trend Changes in Breast Cancer Populations over Two Decades: Insights from the Cancer Genome Atlas Database.